VNDA EBITDA | VANDA PHARMACEUTICALS INC.

VANDA PHARMACEUTICALS INC. (VNDA) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$63.81M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$50.22M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$31.28M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$38.50M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2015-03-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$63.81M	(m)	$50.53M	(m)	$190.00K*	-$31.07M*	(m)	$36.95M	$71.84M	$129.00K
2026-03-31	Reported	(m)	-$50.22M	(m)	$51.72M	(m)	$221.00K	-$50.22M	(m)	$28.43M	$68.36M	$143.00K
2025-09-30	Reported	(m)	-$31.28M	(m)	$56.26M	(m)	$161.00K*	-$31.63M*	(m)	$22.56M	$60.27M	-$5.80M
2025-06-30	Reported	(m)	-$38.50M	(m)	$52.59M	(m)	$299.00K*	-$15.25M*	(m)	$21.99M	$64.62M	-$7.68M
2025-03-31	Reported	(m)	-$41.03M	(m)	$50.04M	(m)	$436.00K	-$33.15M	(m)	$35.71M	$50.08M	-$7.87M
2024-09-30	Reported	(m)	-$11.00M	(m)	$47.65M	(m)	$161.00K*	-$14.58M*	(m)	$16.78M	$37.57M	-$920.00K
2024-06-30	Reported	(m)	-$10.15M	(m)	$50.47M	(m)	$108.00K*	-$6.93M*	(m)	$16.66M	$39.47M	-$998.00K
2024-03-31	Reported	(m)	-$9.23M	(m)	$47.46M	(m)	$7.00K	$7.57M	(m)	$21.15M	$30.09M	-$518.00K
2023-09-30	Reported	(m)	-$6.00M	(m)	$38.81M	(m)	$24.00K*	-$2.05M*	(m)	$16.60M	$24.77M	-$257.00K
2023-06-30	Reported	(m)	-$2.87M	(m)	$46.06M	(m)	$55.00K*	-$13.22M*	(m)	$16.65M	$28.40M	$1.07M
2023-03-31	Reported	(m)	$2.00M	(m)	$62.50M	(m)	$51.00K	$31.80M	(m)	$19.24M	$36.10M	$2.28M
2022-09-30	Reported	(m)	$3.91M	(m)	$65.32M	(m)	$148.00K*	$12.84M*	(m)	$24.86M	$29.85M	$2.19M
2022-06-30	Reported	(m)	$3.46M	(m)	$64.39M	(m)	$193.00K*	$5.68M*	(m)	$21.49M	$33.00M	$1.22M
2022-03-31	Reported	(m)	-$7.67M	(m)	$60.19M	(m)	$75.00K	$4.05M	(m)	$20.97M	$40.85M	-$1.13M
2021-09-30	Reported	(m)	$10.82M	(m)	$70.09M	(m)	-$10.00K*	$9.40M*	(m)	$19.65M	$32.46M	$2.95M
2021-06-30	Reported	(m)	$12.37M	(m)	$67.90M	(m)	$298.00K*	$19.02M*	(m)	$20.25M	$28.35M	$2.95M
2021-03-31	Reported	(m)	$10.34M	(m)	$62.67M	(m)	$130.00K	$9.19M	(m)	$16.13M	$29.80M	$1.78M
2020-12-31	Reported	(m)	$10.45M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Reported	(m)	$7.74M	(m)	$60.31M	(m)	$246.00K*	$9.37M*	(m)	$12.30M	$34.00M	$2.45M
2020-06-30	Reported	(m)	$9.17M	(m)	$62.21M	(m)	$210.00K*	$24.01M*	(m)	$12.90M	$33.92M	$2.38M
2020-03-31	Reported	(m)	-$125.00K	(m)	$58.00M	(m)	$373.00K	-$907.00K	(m)	$15.53M	$37.02M	$755.00K
2019-12-31	Reported	(m)	$4.24M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	(m)	$10.76M	(m)	$59.48M	(m)	$294.00K*	$6.00M*	(m)	$11.35M	$30.22M	-$88.15M
2019-06-30	Reported	(m)	$9.89M	(m)	$59.06M	(m)	$264.00K*	$20.52M*	(m)	$10.95M	$31.47M	$18.00K
2019-03-31	Reported	(m)	-$2.09M	(m)	$47.71M	(m)	$393.00K	$9.64M	(m)	$13.28M	$31.03M	$10.00K
2018-12-31	Reported	(m)	$9.15M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Reported	(m)	$6.23M	(m)	$49.13M	(m)	$136.00K*	(m)	(m)	$11.39M	$26.05M	$92.00K
2018-06-30	Reported	(m)	$3.91M	(m)	$47.35M	(m)	$75.00K*	(m)	(m)	$9.87M	$27.96M	$90.00K
2018-03-31	Reported	(m)	$2.44M	(m)	$43.59M	(m)	$135.00K	(m)	(m)	$9.42M	$26.82M	-$2.00K
2017-12-31	Reported	(m)	-$2.15M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Reported	(m)	-$4.92M	(m)	(m)	(m)	$371.00K*	(m)	(m)	$10.18M	$31.12M	$23.00K
2017-06-30	Reported	(m)	-$1.92M	(m)	(m)	(m)	$624.00K*	(m)	(m)	$7.65M	$31.37M	$7.00K
2017-03-31	Reported	(m)	-$7.91M	(m)	(m)	(m)	$478.00K	(m)	(m)	$10.57M	$30.30M	$19.00K
2016-12-31	Reported	(m)	-$654.00K	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	(m)	-$653.00K	(m)	(m)	(m)	$599.00K*	(m)	(m)	$7.29M	$21.91M	$0.00
2016-06-30	Reported	(m)	-$4.79M	(m)	(m)	(m)	(m)	(m)	(m)	$6.70M	$24.68M	$0.00
2016-03-31	Reported	(m)	-$12.47M	(m)	(m)	(m)	(m)	(m)	(m)	$7.55M	$29.29M	$0.00
2015-12-31	Reported	(m)	-$14.89M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	-$9.38M*	-$9.54M	$157.00K*	(m)	(m)	$874.00K*	(m)	(m)	$9.97M	$18.46M	$0.00
2015-06-30	Reported	-$5.33M*	-$5.46M	$123.00K*	(m)	(m)	$156.00K*	(m)	(m)	$5.95M	$18.39M	$0.00
2015-03-31	Reported	-$10.15M	(m)	(m)	(m)	-45.84%	$783.00K	(m)	(m)	$4.48M	$18.81M	$0.00
2014-12-31	Reported	$69.83M	(m)	(m)	(m)	454.34%	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$1.32M*	-$1.45M	$132.00K*	(m)	(m)	$53.00K*	(m)	(m)	$3.70M	$11.29M	(m)
2014-06-30	Reported	-$21.47M*	-$21.61M	$139.00K*	(m)	(m)	$243.00K*	(m)	(m)	$3.51M	$28.14M	(m)
2014-03-31	Reported	-$26.45M	(m)	(m)	(m)	-289.33%	$135.00K	-$23.90M	(m)	$7.26M	$27.89M	(m)
2013-12-31	Reported	-$7.68M	(m)	(m)	(m)	-87.44%	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$5.32M*	-$5.43M	$109.00K*	(m)	(m)	$7.00K*	-$10.27M*	(m)	$8.02M	$5.74M	(m)
2013-06-30	Reported	-$3.31M*	-$3.41M	$105.00K*	(m)	(m)	$49.00K*	-$8.04M*	(m)	$6.10M	$5.26M	(m)
2013-03-31	Reported	-$4.46M	(m)	(m)	(m)	-55.26%	$23.00K	-$9.13M	(m)	$8.11M	$4.15M	(m)
2012-12-31	Reported	-$7.28M	(m)	(m)	(m)	-91.87%	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$5.29M*	-$5.39M	$104.00K*	(m)	(m)	$17.00K*	-$10.16M*	(m)	$10.16M	(m)	(m)
2012-06-30	Reported	-$7.99M*	-$8.09M	$93.00K*	(m)	(m)	$148.00K*	-$12.21M*	(m)	$12.49M	(m)	(m)
2012-03-31	Reported	-$7.99M	(m)	(m)	(m)	-98.10%	$1.84M	-$8.69M	(m)	$12.18M	(m)	(m)
2011-12-31	Reported	-$5.72M	(m)	(m)	(m)	-68.38%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$3.15M*	-$3.29M	$146.00K*	(m)	(m)	$34.00K*	-$7.17M*	(m)	$8.17M	(m)	-$113.00K
2011-06-30	Reported	-$1.45M*	-$1.51M	$61.00K*	(m)	(m)	(m)	-$5.62M*	(m)	$6.00M	(m)	-$51.00K
2011-03-31	Reported	$84,000.00	(m)	(m)	(m)	1.12%	(m)	-$3.26M	(m)	$4.27M	(m)	$6.00K
2010-12-31	Reported	$869,000.00	(m)	(m)	(m)	11.21%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	$822.00K*	$743.00K	$79.00K*	(m)	(m)	(m)	-$5.07M*	(m)	$4.07M	(m)	-$2.29M
2010-06-30	Reported	(m)	$1.16M	(m)	(m)	(m)	(m)	(m)	(m)	$2.40M	(m)	-$37.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	-$151.17M	(m)	$216.10M	(m)	$998.00K	-$109.44M	(m)	$109.27M	$237.95M	$81.83M
2024-12-31	Reported	(m)	-$40.66M	(m)	$198.77M	(m)	$490.00K	-$15.76M	(m)	$74.43M	$146.41M	-$4.02M
2023-12-31	Reported	(m)	-$13.95M	(m)	$192.64M	(m)	$383.00K	$12.80M	(m)	$76.82M	$112.88M	$3.83M
2022-12-31	Reported	(m)	$6.33M	(m)	$254.38M	(m)	$679.00K	$31.98M	(m)	$85.77M	$136.49M	$5.03M
2021-12-31	Reported	(m)	$42.16M	(m)	$268.68M	(m)	$552.00K	$64.21M	(m)	$75.36M	$124.05M	$9.21M
2021-09-30	Rolling	(m)	$43.98M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-06-30	Rolling	(m)	$40.90M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2021-03-31	Rolling	(m)	$37.70M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-12-31	Reported	(m)	$27.24M	(m)	$248.17M	(m)	$1.79M	$51.77M	(m)	$55.58M	$140.51M	$8.32M
2020-12-31	Rolling	(m)	$27.24M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-09-30	Rolling	(m)	$21.03M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	$24.05M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	$24.77M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	(m)	$22.81M	(m)	$227.19M	(m)	$1.02M	$45.95M	(m)	$48.65M	$129.74M	-$86.53M
2019-12-31	Rolling	(m)	$22.81M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	$27.72M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-06-30	Rolling	(m)	$23.19M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-03-31	Rolling	(m)	$17.21M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-12-31	Reported	(m)	$21.74M	(m)	$193.12M	(m)	$368.00K	$29.99M	(m)	$43.59M	$105.75M	$138.00K
2018-12-31	Rolling	(m)	$21.74M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-09-30	Rolling	(m)	$10.44M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$718.00K*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$6.55M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-12-31	Reported	(m)	-$16.90M	(m)	$165.08M	(m)	$1.66M	-$1.98M	(m)	$38.55M	$123.84M	$136.00K
2017-12-31	Rolling	(m)	-$16.90M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$15.41M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$11.14M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$14.00M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	(m)	-$18.57M	(m)	$146.02M	(m)	$1.41M	(m)	(m)	$29.16M	$99.79M	$104.00K
2016-12-31	Rolling	(m)	-$18.57M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$32.81M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$41.70M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$42.37M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	(m)	-$40.19M	(m)	(m)	(m)	$2.53M	(m)	(m)	$29.14M	$84.53M	$0.00
2015-12-31	Rolling	(m)	-$40.19M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	$44.40M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	$52.49M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	$36.35M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	$20.59M	(m)	(m)	(m)	41.06%	$769.00K	(m)	(m)	$19.23M	$84.64M	$0.00
2014-12-31	Rolling	(m)	$20.06M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	-$57.42M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-30	Rolling	(m)	-$61.41M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Rolling	(m)	-$43.21M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	-$20.77M	(m)	(m)	(m)	-61.30%	$176.00K	-$39.59M	(m)	$28.50M	$25.08M	$0.00
2013-12-31	Rolling	(m)	-$21.20M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Rolling	(m)	-$19.84M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-06-30	Rolling	(m)	-$19.80M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	Rolling	(m)	-$24.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	-$28.55M	(m)	(m)	(m)	-87.22%	$2.02M	-$44.92M	(m)	$45.76M	$14.52M	(m)
2012-12-31	Rolling	(m)	-$28.23M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Rolling	(m)	-$27.70M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-06-30	Rolling	(m)	-$25.60M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-03-31	Rolling	(m)	-$19.03M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-12-31	Reported	-$10.24M	(m)	(m)	(m)	-32.74%	$275.00K	-$28.41M	(m)	$29.00M	(m)	-$444.00K
2011-12-31	Rolling	(m)	-$10.71M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	$9.17M	(m)	(m)	(m)	25.69%	(m)	-$10.90M	(m)	$12.34M	(m)	$2.08M
2009-12-31	Reported	-$35.51M	(m)	(m)	(m)	-780.69%	(m)	$169.34M	(m)	$13.87M	(m)	(m)

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
STANDARD BIOTOOLS INC. (LAB)	United States	$0.297B	3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)	United States	$0.296B	-21.78
GT Biopharma, Inc. (GTBP)	United States	$0.309B	-4.58
ABEONA THERAPEUTICS INC. (ABEO)	United States	$0.312B	-5.63
Fulcrum Therapeutics, Inc. (FULC)	United States	$0.289B	-3.28
Contineum Therapeutics, Inc. (CTNM)	United States	$0.289B	-4.40
Prelude Therapeutics Inc (PRLD)	United States	$0.318B	-7.01
Perspective Therapeutics, Inc. (CATX)	United States	$0.284B	-3.34
Evommune, Inc. (EVMN)	United States	$0.320B	-5.10
Upstream Bio, Inc. (UPB)	United States	$0.284B	-2.42